5 Drug/Biotech Stocks Set To Beat Estimates In Q4 Earnings
Zacks Investment Research | Feb 14, 2019 12:58AM ET
The fourth-quarter earnings season has crossed the half way mark. Per the latest Earnings ESP Filter .
Bet on These 5 Stocks for Robust Returns
Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) has an Earnings ESP of +3.39% and a Zacks Rank #3. The Zacks Consensus Estimate for fourth-quarter 2018 is pegged at a loss of 55 cents. The company has average trailing four-quarter positive surprise of 6.77%. It is scheduled to release financial figures on Feb 28.
Recro Pharma, Inc. (NASDAQ:REPH) has an Earnings ESP of +3.03% and a Zacks Rank #2. The Zacks Consensus Estimate for fourth-quarter 2018 stands at a loss of 74 cents. The company has average earnings surprise of 23.4% in the last four reported quarters. It is scheduled to report earnings numbers on Feb 19.
Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) has an Earnings ESP of +32.24% and a Zacks Rank of 3. The Zacks Consensus Estimate for fourth-quarter 2018 is pegged at 25 cents. The company came up with average beat of 164.8% in the previous four reported quarters.
Puma Biotechnology, Inc (NASDAQ:PBYI) has an Earnings ESP of +0.54% and is a #3 Ranked stock. The Zacks Consensus Estimate for fourth-quarter 2018 is pegged at a loss of 92 cents. The company has average trailing four-quarter positive surprise of 67.31%. It is scheduled to report results on Feb 28.
Epizyme, Inc. (NASDAQ:EPZM) has an Earnings ESP of +7.93% and is a Zacks #3 Ranked player. The Zacks Consensus Estimate for fourth-quarter 2018 is pegged at a loss of 49 cents. The company pulled off average positive surprise of 11.97% in the preceding four reported quarters.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.